Position Statement On The Role Of Vitamin D In Postmenopausal Women Published In Maturitas

January 28, 2012 by · Leave a Comment 

Elsevier, a world-leading provider of scientific, technical and medical information products and services, has announced the publication of a position statement by the European Menopause and Andropause Society (EMAS) in journal Maturitas on the role of vitamin D in postmenopausal women with summary recommendations. Vitamin D deficiency is common and may affect up to 70% of Europeans…

Older Women On Statins Have Higher Risk Of Diabetes

January 22, 2012 by · Leave a Comment 

According to a study published Online First in the Archives of Internal Medicine, one of the JAMA/Archives journals, using statins in postmenopausal women, is linked to an increased risk of diabetes…

Bionovo Initiates Menerba (MF101) Phase 3 Clinical Trial For Menopausal Hot Flashes

January 9, 2012 by · Leave a Comment 

Bionovo, Inc. (Nasdaq: BNVI), a pharmaceutical company focused on the discovery and development of safe and effective treatments for women’s health and cancer, announced that enrollment has started to the Phase 3 pivotal clinical trial evaluating the safety and efficacy of two doses of Menerbaâ„¢ (MF101) among a cohort of postmenopausal women for the treatment of menopausal hot flashes…

Yoga may ease insomnia, menopause problems

December 2, 2011 by · Leave a Comment 

NEW YORK (Reuters Health) – A couple of yoga sessions a week could help ease sleep problems and other effects of menopause, a small study suggests. The study, reported in the journal Menopause, included postmenopausal women diagnosed with insomnia. “We are not saying that yoga can cure postmenopausal symptoms,” Dr. Helena Hachul, one of the study authors, wrote in an email to Reuters Health …

Unigene Announces Positive Top-Line Results Of Phase 2 Oral PTH Study For The Treatment Of Osteoporosis In Postmenopausal Women

November 13, 2011 by · Leave a Comment 

Unigene Laboratories, Inc. (OTCBB: UGNE), a leader in the design, delivery, manufacture and development of peptide-based therapeutics, today announced positive top-line results of its Phase 2 clinical study evaluating an experimental oral parathyroid hormone (PTH) analog for the treatment of osteoporosis in 93 postmenopausal women…

Next Page »